FDA 483 - Intas Pharmaceuticals Limited - December 14, 2018
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Intas Pharmaceuticals Limited in Ahmedabad, India, was inspected by the FDA from December 10-14, 2018. The inspection revealed a significant issue regarding the failure to follow procedures designed to prevent microbiological contamination during the manufacturing of sterile drug products. Specifically, an operator was not monitored in the aseptic filling room as required by the firm's own SOPs, and logbooks lacked documentation of critical activities or personnel monitoring.
ID · d7d4f9f0-3246-4bd4-b45d-b1149c0a717e